Fundraising Fox

Bart De Leeuw

Investor

Partner/CFO at Fund+

Belgium

About

Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.

Experience

  1. FundPlusPartnercurrent2023 — present
  2. EyeD PharmaBoard Membercurrent2023 — presentLiege Metropolitan Area
  3. UniD ManufacturingBoard Membercurrent2023 — presentLiege Metropolitan Area
  4. Coave TherapeuticsBoard Membercurrent2023 — presentGreater Paris Metropolitan Region
  5. EPICS TherapeuticsBoard Membercurrent2024 — presentGosselies
  6. WOLLUXCEO2021 — 2023Kortrijk, Flemish Region, Belgium
  7. Koramic Visual CommunicationMember Of The Management Board2021 — 2023Mouscron, Walloon Region, Belgium
  8. Fortino Capital PartnersCFO2019 — 2020Antwerpen Berchem, Vlaanderen, België
  9. Ackermans & van HaarenFinance2016 — 2019
  10. Ernst&YoungIFRS2002 — 2016
  11. Wolters Kluwer Financial Services | FinArchBusiness Consultant2000 — 2002Greater Boston
  12. BNP Paribas FortisConsolidatie1996 — 2000

Education

  1. HUB-KUBrussel

Skills & more

Financial Reporting10Financial Analysis2International Financial Reporting Standards (IFRS)Internal Controls5Finance1Financial Accounting4Accounting4Financial Audits3Management ConsultingCorporate Finance1IFRS18US GAAP2
+1 moreInternal Audit

From Bart's professional profile.

Same school

Shared employers

Colleagues at Fund+